Hyaluronic acid lyase and application thereof in degrading hyaluronic acid

By cloning from Enterobacteria and recombinantly expressing hyaluronic acid lyase in E. coli, the problems of high cost and complex process in the prior art are solved, and high-efficiency degradation of high molecular weight hyaluronic acid to low molecular weight or The effect of oligopolymerized hyaluronic acid provides safe and excellent microbial-derived enzymes.

CN119020338AActive Publication Date: 2024-11-26JIANGNAN UNIV +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411206449.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-26
Estimated Expiration
2044-08-30

AI Technical Summary

Technical Problem

The existing hyaluronidases are mainly derived from animal tissues, with high cost and complex processes, and lack safe and excellent properties of microbial hyaluronidase.

Method used

By cloning the hyaluronic acid lyase gene from Enterobacter asburiae and recombinantly expressing it in E. coli, hyaluronic acid lyase with an enzyme activity of up to 36715U/mL is obtained. It has high selectivity and good catalytic performance and can be efficient. Degraded high molecular weight hyaluronic acid is low molecular weight or oligomeric hyaluronic acid.

Benefits of technology

It has achieved efficient production of unsaturated hyaluronic acid disaccharides. The enzyme has a high substrate specificity for hyaluronic acid, high degradation efficiency, and an appropriate pH and temperature range, which is suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020338A_ABST
    Figure CN119020338A_ABST
Patent Text Reader

Abstract

The invention discloses hyaluronate lyase and application of the hyaluronate lyase in degradation of hyaluronic acid. Specifically, the invention provides the hyaluronate lyase derived from Enterobacter asbriae, the encoding gene of the hyaluronate lyase is cloned, recombinant expression is realized in an escherichia coli system, and the enzyme activity is up to 36715 U / mL. An enzymatic property characterization experiment shows that the enzyme can play a role in degrading hyaluronic acid in a pH range of 6.5-9.0, has relatively high substrate specificity on hyaluronic acid, can degrade hyaluronic acid with relatively high molecular weight into hyaluronic acid with low molecular weight or oligomeric hyaluronic acid in a short time, is high in degradation efficiency, and has a good application prospect. The final degradation product is unsaturated hyaluronic acid disaccharide. The hyaluronate lyase provided by the invention can efficiently produce unsaturated hyaluronate disaccharide, and lays a foundation for subsequent further research on activity evaluation of hyaluronate oligosaccharide.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a hyaluronate lyase and application thereof in degrading hyaluronic acid, belonging to the technical field of enzyme engineering. Background Art

[0002] Hyaluronic acid (HA), commonly known as hyaluronic acid, is a macromolecular acidic mucopolysaccharide composed of D-glucuronic acid and N-acetylglucosamine as repeating disaccharide units, connected alternately by β-(1,3) and β-(1,4) glycosidic bonds. The hydrophilicity, viscoelasticity and biocompatibility of hyaluronic acid have made it widely concerned and applied in the fields of medicine, beauty, food, etc.

[0003] In recent years, studies have found that hyaluronic acid (HA) with a relatively small molecular weight, especially o-HAs (oligosaccharides with a relative molecular weight of less than 10k), has very important biological functions. For example, o-HAs has the effects of promoting angiogenesis, promoting wound repair, inhibiting multidrug resistance of tumor cells, etc., and has potential application value in medicine, cosmetics and health products. 4 Da) show both anti-inflammatory and pro-inflammatory properties, depending on the cell type and disease. Some studies have shown that o-HAs can reduce toll-like receptor (TLRs)-mediated inflammation, inhibit HA-CD44 activation of kinases, and delay tumor growth. However, o-HAs have also been found to promote inflammation in synovial fibroblasts, stimulate cell adhesion, and enhance angiogenesis. Unsaturated hyaluronic acid disaccharides exhibit unique anti-inflammatory activity. Therefore, it is of great significance to prepare hyaluronic acid with a specific molecular weight.

[0004] Hyaluronidase (HAase) can degrade hyaluronic acid into o-HAs and is the most important method for preparing o-HAs. Research on hyaluronidase has gradually become a hot topic. Hyaluronidase is widely distributed in natural organisms and has been found in mammals, invertebrates (crustaceans, leeches and insects), pathogenic fungi (Candida, Streptomyces), bacteria and bacteriophages. At present, it has been found that a variety of microorganisms can produce hyaluronidase, mostly concentrated in Arthrobacter, Pasteurella, Streptococcus zooepidemicus, Bacillus, etc. All known hyaluronidases from microorganisms are lytic enzymes that can degrade the β-(1,4) glycosidic bonds of hyaluronic acid to form oligosaccharides containing unsaturated double bonds. Compared with enzymes from animals, enzymes from microorganisms have the characteristics of high yield, strong activity, diverse properties, and easy heterologous recombinant expression, and are the main research objects of industrial enzyme preparations.

[0005] Currently, most of the hyaluronidases available on the market are extracted from animal tissues, which are costly and relatively complex. Therefore, it is necessary to clarify the characteristics of hyaluronidase produced by microorganisms and understand the properties of hyaluronidase from microbial sources as soon as possible, so as to obtain more safe and high-quality hyaluronidases. Summary of the invention

[0006] To solve the above problems, the present invention provides a hyaluronan lyase derived from Enterobacter asburiae, which has an enzyme activity of up to 36715U / mL when recombinantly expressed in Escherichia coli, has high selectivity and good catalytic performance for the substrate hyaluronic acid, performs well in degrading hyaluronic acid to generate oligosaccharides such as hyaluronan disaccharide, and is superior to the hyaluronic acid lyases currently reported in terms of degradation speed.

[0007] The first object of the present invention is to provide a hyaluronan lyase, the amino acid sequence of the hyaluronan lyase is shown as SEQ ID NO.1.

[0008] The second object of the present invention is to provide a gene encoding the hyaluronan lyase.

[0009] Furthermore, the sequence of the gene is shown in SEQ ID NO.2.

[0010] The third object of the present invention is to provide a recombinant expression vector carrying the gene.

[0011] The fourth object of the present invention is to provide an expression cassette containing the gene.

[0012] Furthermore, the expression cassette includes elements necessary for expressing the gene and / or elements that assist in expression, such as a promoter, a terminator, a signal peptide, an RBS, and the like.

[0013] The fifth object of the present invention is to provide a recombinant bacterium expressing the hyaluronan lyase.

[0014] Furthermore, the host bacteria of the recombinant bacteria include Escherichia coli.

[0015] The sixth object of the present invention is to provide a method for producing hyaluronan lyase, comprising the step of fermentation production using the recombinant bacteria.

[0016] Furthermore, during the fermentation production process, the pH is preferably 7.0-8.0, and the temperature is preferably 20-40°C.

[0017] Furthermore, in the fermentation production process, the seed culture medium or the fermentation culture medium is LB culture medium, which includes: 8-12 g / L tryptone, 3-7 g / L yeast powder, and 8-12 g / L sodium chloride.

[0018] The seventh object of the present invention is to provide the use of the hyaluronan lyase in degrading hyaluronic acid.

[0019] Furthermore, the hyaluronic acid is high molecular weight hyaluronic acid and / or medium molecular weight hyaluronic acid, such as hyaluronic acid with a molecular weight of 1000-2000 kDa, more preferably 1000-1500 kDa.

[0020] Furthermore, the application is to degrade high molecular weight hyaluronic acid or medium molecular weight hyaluronic acid into low molecular weight hyaluronic acid or oligomeric hyaluronic acid in a short time (such as 30 min, 40 min, 50 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h or any time longer than 6 h), preferably, the average molecular weight is lower than 20 kDa, lower than 10 kDa, lower than 5 kDa, lower than 1 kDa or even lower than 500 Da.

[0021] Furthermore, the conditions for degrading hyaluronic acid are: reaction temperature 25-45° C., reaction pH 6.5-9.0, and hyaluronic acid concentration 1-20 g / L.

[0022] The eighth object of the present invention is to provide a method for producing low molecular weight hyaluronic acid or oligomeric hyaluronic acid, comprising the steps of using high molecular weight hyaluronic acid or medium molecular weight hyaluronic acid as a substrate and using the hyaluronan lyase as a catalyst for preparation.

[0023] Further, the reaction time is at least 1 hour, more preferably at least 2 hours.

[0024] Furthermore, the oligomeric hyaluronic acid includes but is not limited to hyaluronic acid disaccharide, hyaluronic acid tetrasaccharide, hyaluronic acid hexasaccharide, hyaluronic acid octasaccharide, hyaluronic acid decasaccharide, hyaluronic acid dodecasaccharide and the like.

[0025] Beneficial effects of the present invention:

[0026] The present invention provides a kind of hyaluronan lyase and its application in degrading hyaluronic acid, wherein hyaluronan lyase is derived from Enterobacter asburiae, and the present invention realizes recombinant expression by cloning its coding gene and in Escherichia coli system, and the enzyme activity reaches 36715U / mL, and the protein molecular weight is 87.88kDa. Enzyme property characterization experiment shows that the enzyme can play a hyaluronic acid degradation effect in the range of pH 6.5-9.0, the optimum pH is 7.0, and the optimum reaction temperature is 40 DEG C. More importantly, the enzyme has a high substrate specificity for hyaluronic acid, and the degradation efficiency is high, and the enzyme of 100U / mL can reduce the hyaluronic acid of average molecular weight 1360kDa to less than 20kDa in 1h, and the final degradation product is unsaturated hyaluronic acid disaccharide. The hyaluronan lyase provided by the present invention can efficiently produce unsaturated hyaluronic acid disaccharides. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 The nucleic acid electrophoresis diagram of PCR amplification of the hyaluronic acid lyase encoding gene and colony PCR verification of E.coli BL21 / pET22b(+)-HylEP0006. Among them, (a) lanes 1-5 are the amplified hyaluronic acid lyase encoding gene; lane M: 10,000bp DNAMarker. (b) is the nucleic acid electrophoresis diagram of colony PCR verification after the successful construction of E.coli BL21 / pET22b(+)-HylEP0006. Lanes 1-5 are the gene fragments carrying the target gene obtained by PCR amplification of the recombinant bacterial colony; lane M: 5,000bp DNAMarker.

[0028] Figure 2 This is the SDS-PAGE profile of the purified hyaluronan lyase HylEP0006. Lane Hyl: HylEP0006; Lane M: protein marker.

[0029] Figure 3 The optimal reaction temperature (a) and the optimal reaction pH (b) of HylEP0006.

[0030] Figure 4 The enzymatic hydrolysis curves of HylEP0006 for substrates of different concentrations (a) and the double reciprocal plot of the enzymatic kinetic parameters (b).

[0031] Figure 5HPLC graphs of 100 U / mL HylEP0006 on hyaluronic acid (2 g / L) at different degradation times: 1 h (a), 2 h (b), and 6 h (c).

[0032] Figure 6 This is a graph showing the concentration changes of each component of hyaluronic acid (2 g / L) after degradation by 100 U / mL HylEP0006 at different times (1 h, 2 h, 6 h).

[0033] Figure 7 MS graph (a) and thin layer chromatography analysis (b) of hyaluronic acid (2 g / L) degradation by 100 U / mL HylEP0006 for 6 h. DETAILED DESCRIPTION

[0034] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0035] The method and materials involved in the present invention are as follows:

[0036] (1) Method for determining the activity of hyaluronan lyase

[0037] Preparation of 2 g / L hyaluronic acid substrate: Dissolve 2 g hyaluronic acid in 1 L 50 mM phosphate buffer to prepare a 2 g / L hyaluronic acid substrate solution.

[0038] Determination method: The reducing end content produced by hyaluronic acid degradation by hyaluronic acid lyase was determined according to the 3,5-dinitrohydrochloric acid (DNS) colorimetric method. The enzyme solution and hyaluronic acid solution were used as the experimental group, and the inactivated enzyme solution and hyaluronic acid solution were used as the control group. The reaction was carried out at 37°C for 15 minutes, and the DNS reagent was added. The reaction was terminated by boiling water bath for 10 minutes. After cooling, the absorbance was measured at 540nm using an enzyme reader. Glucose solutions of different concentrations were prepared to establish a glucose standard curve.

[0039] Enzyme activity calculation method: Enzyme activity unit (1U) is defined as the amount of enzyme required to produce 1 μg of glucose reducing equivalent per minute under the above experimental conditions. The determination was repeated 3 times. This is used as the standard determination method for hyaluronan lyase activity.

[0040] (2) Culture medium

[0041] LB medium: 10 g / L tryptone, 5 g / L yeast powder, 10 g / L sodium chloride.

[0042] (3)Strain

[0043] In the early stage, a strain of Enterobacter asburiae that grows on hyaluronic acid as the sole carbon source was screened in river water, and hyaluronan lyase was amplified from this strain.

[0044] (4) Sequence

[0045] HylEP0006 amino acid sequence (SEQ ID NO.1):

[0046] *

[0047] HylEP0006 nucleotide sequence (SEQ ID NO.2):

[0048]

[0049] (5) Hyaluronic acid

[0050] In the hyaluronic acid involved in the present invention:

[0051] High molecular weight hyaluronic acid refers to hyaluronic acid with a molecular weight higher than 2000KDa;

[0052] Medium molecular weight hyaluronic acid refers to hyaluronic acid with a molecular weight between 50KDa-2000KDa;

[0053] Low molecular weight hyaluronic acid refers to hyaluronic acid with a molecular weight between 10KDa and 50KDa;

[0054] Oligomeric hyaluronic acid refers to a hyaluronic acid molecule with a molecular weight of less than 10KDa, that is, less than 50 monosaccharide structures and a degree of polymerization of less than 25.

[0055] In addition, the average molecular weight of the hyaluronic acid raw material involved in the present invention is 1360 kDa.

[0056] Example 1: Recombinant expression and purification of hyaluronan lyase

[0057] A gene of polysaccharide lyase 8 family in the Enterobacterales genome was obtained from the NCBI database, and primers HylEP0006-IF

[0058] (5'-aattaattcggatccgaattcATGAAAAAGACAAATTTAGCAT-3'), HylEP0006-1R (5'-aattaattcggatccgaattcGCACAGATCGCTACC-3'). PCR amplification was performed using the genome as a template, and the amplified product was recovered ( Figure 1 a), and linearize the pET22b(+) plasmid with reverse PCR primers and recover it. Use a one-step homologous recombination cloning kit to connect the PCR amplification product and the linearized plasmid and transfer them into E.coli BL21(DE3) for plating culture, and take a single colony for colony PCR identification ( Figure 1 b), OD 600 =0.4, 0.02 mM IPTG was used to induce expression, and the fermentation was carried out at 20°C for 24 h. The cells were collected by centrifugation, resuspended in pH 7.0 phosphate buffer, ultrasonically disrupted for 15 min, and the supernatant was collected by centrifugation for enzyme activity determination and SDS-PAGE electrophoresis analysis.

[0059] The results showed that the gene length of hyaluronan lyase HylEP0006 was 2379bp, encoding 792 amino acids (amino acid sequence see SEQ ID NO.1, gene sequence see SEQ ID NO.2). Comparison with other hyaluronan lyases in the NCBI database revealed that HylEP0006 had the greatest similarity of 80.77% with the hyaluronan lyase from Citrobacter freundii (GenBank ID: WEA82373.1). The enzyme activity of the recombinant bacteria E.coli BL21 / pET22b(+)-HylEP0006 reached 36715U / mL. The recombinant protein was purified by nickel ion affinity chromatography to obtain the HylEP0006 recombinant enzyme of electrophoresis grade purity. The SDS-PAGE results showed that the protein size of HylEP0006 was about 90kDa, close to the theoretical molecular weight of 87kDa, which was in line with expectations ( Figure 2 ).

[0060] Example 2: Determination of the enzymatic properties of hyaluronan lyase

[0061] In order to investigate the degradation activity of hyaluronan lyase on hyaluronic acid at different temperatures, the enzyme reaction temperature was changed, and the hyaluronan lyase activity was measured at various temperatures to obtain the optimal reaction temperature. The temperature gradient was set to 25°C, 30°C, 32.5°C, 35°C, 37.5°C, 40°C, 42.5°C, 45°C, and 50°C, and the enzyme activity at pH 7.0 and 40°C (35539U / mL) was taken as 100% relative enzyme activity.

[0062] The pH of the substrate was changed (3.0, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 8.0, 9.0), and the enzyme activity was measured to determine the optimal reaction pH, with the enzyme activity at pH 7.0 and 40°C being taken as 100%.

[0063] In order to characterize the effect of metal ions on enzyme activity, the final concentrations of metal ions were 1 and 10 mmol / L, respectively. 3+ Mg 2+ , Cu 2+ 、Zn 2+ , Fe 3+ , Ba 2+ , Li + , K + , Ca 2+ ) incubation system, incubate the enzyme solution at room temperature for 1 hour, and use the reaction without adding metal ions as a control for enzyme activity detection.

[0064] The results showed that the optimal reaction temperature of the hyaluronan lyase HylEP0006 of the present invention was 40°C, and the relative enzyme activity was more than 80% in the range of 30-45°C. Figure 3 a). The optimum pH of HylEP0006 is 7.0 ( Figure 3 b) The different metal ions Al 3+ Mg 2+ 、Na + 、Zn 2+ , Fe 3+ , Ba 2+ , Li + , K + , Ca 2+ The effect of Ca on enzyme activity was compared with the enzyme solution without any metal ions added. 2+ When it is 1mmol / L, it has a promoting effect on hyaluronan lyase, while Al 3+ 、Na + 、Zn 2+ , Fe 3+ and Cu 2+ The enzyme activity was significantly inhibited; when the concentration was increased to 10mmol / L, Mg 2+ , Ca 2+ They all have a promoting effect on hyaluronan lyase, and with the increase of the concentration of the two metal ions, the promoting effect becomes more and more obvious, while the other metal ions show an inhibitory trend on the activity of hyaluronan lyase.

[0065] Table 1 Effects of metal ions on hyaluronan lyase HylEP0006

[0066]

[0067] Note: ND means no enzyme activity was detected

[0068] Example 3: Determination of substrate specificity and kinetic parameters of hyaluronan lyase

[0069] To investigate the substrate specificity of hyaluronan lyase, 2g / L hyaluronic acid, chondroitin sulfate, sodium heparin, sodium alginate and chitosan solutions were prepared in pH 7.0 phosphate buffer for determination of the enzymatic activity of HylEP0006, and the degradation activity of hyaluronic acid was 100%. To investigate the kinetic parameters of hyaluronic acid degradation, a series of hyaluronic acid solutions of different concentrations of 0.02-0.16mg / mL were prepared in pH 7.0 phosphate buffer and mixed with the enzyme solution, and the enzymatic kinetic curve was drawn by the absorbance of the reaction solution at 232nm in the real-time detection system, and the Km value and Vmax value were obtained by double reciprocal plotting.

[0070] The results showed that HylEP0006 had a high substrate specificity for hyaluronic acid and only 6.33% relative enzyme activity for chondroitin sulfate (Table 1). Through double reciprocal plotting, the maximum reaction rate of hyaluronic acid lyase HylEP0006 was V max =1.075A 232 / min, Michaelis constant K m =1.636mg / mL( Figure 4 a,b).

[0071] Table 2 Substrate specificity of hyaluronan lyase

[0072]

[0073] Example 4: Characterization of the degradation characteristics of hyaluronan by hyaluronan lyase

[0074] In order to verify the degradation characteristics of hyaluronic acid by hyaluronan lyase HylEP0006, 2 g / L hyaluronic acid solution was prepared with pH 7.0 phosphate buffer, and the enzyme solution was added to the reaction system until its concentration was 100 U / mL. The reaction was stirred at 37°C and samples were taken at 1, 2, and 6 hours. The oligosaccharide distribution was detected by HPLC, the average relative molecular weight of the degradation product was detected by GPC gel permeation chromatography, and the final degradation product was detected by ESI-MS and TLC thin layer chromatography.

[0075] HPLC results showed that after 1 hour of degradation, hyaluronic acid 2-, 4-, 6-, 8- and 10-sugars were generated in the product, but the amount of 2-sugar was the largest and accumulated continuously. After 2 hours, the content of 6-, 8- and 10-sugars in the product gradually decreased, while the content of 2- and 4-sugars increased, but at 6 hours, only 2-sugar accumulated ( Figure 5 ,6). GPC results showed that 100U / mL HylEP0006 could quickly reduce the average molecular weight of hyaluronic acid from 1360kDa to below 20kDa within 1h (Table 3). The final product of hyaluronic acid degradation by HylEP0006 was analyzed. The mass-to-charge ratio of the main peak observed in the mass spectrum was 378, which was consistent with the molecular weight of the unsaturated disaccharide. Combined with the TLC results, the final product was an unsaturated hyaluronic acid disaccharide with N-acetylglucosamine at the reducing end ( Figure 7 a,b).

[0076] Table 3 Viscosity and average molecular weight of hyaluronic acid at different enzymatic hydrolysis times

[0077]

[0078] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.

Claims

1. A hyaluronate lyase, characterized in that The amino acid sequence of the hyaluronan lyase is shown in SEQ ID NO.

1.

2. A gene encoding the hyaluronan lyase according to claim 1.

3. A recombinant expression vector carrying the gene according to claim 2.

4. An expression cassette containing the gene according to claim 2.

5. A recombinant bacterium expressing the hyaluronate lyase according to claim 1.

6. A method for producing hyaluronate lyase, characterized in that: The method comprises the step of using the recombinant bacteria described in claim 5 for fermentation production.

7. Use of the hyaluronan lyase according to claim 1 in degrading hyaluronic acid.

8. The use according to claim 7, characterized in that: The application comprises using the hyaluronan lyase to degrade high molecular weight hyaluronan or medium molecular weight hyaluronan into low molecular weight hyaluronan or oligomeric hyaluronan.

9. A method for producing low molecular weight hyaluronic acid or oligomeric hyaluronic acid, characterized in that: The method comprises the steps of using high molecular weight hyaluronic acid or medium molecular weight hyaluronic acid as a substrate and the hyaluronic acid lyase according to claim 1 as a catalyst for preparation.

10. The method according to claim 9, characterized in that The oligomeric hyaluronic acid includes hyaluronic acid disaccharide, hyaluronic acid tetrasaccharide, hyaluronic acid hexasaccharide, hyaluronic acid octasaccharide, hyaluronic acid decasaccharide or hyaluronic acid dodecasaccharide.

Citation Information

Patent Citations

  • Citrobacter vinegaticus, hyaluronidase as well as preparation method and application of hyaluronidase

    CN117568222A